High-Throughput Analysis of Epigenetic Targets with Agilent RapidFire/MS Systems: Sirtuin (SIRT) Enzymes

Significance of the Topic

The sirtuin family of NAD+-dependent deacetylases regulates critical posttranslational modifications on histone and nonhistone proteins, influencing processes such as inflammation, metabolism, neurodegeneration, and cancer. High-throughput, label-free assays that directly monitor these enzymatic activities are essential for identifying modulators of sirtuins and other epigenetic targets during drug discovery and biomarker research.

Study Objectives and Overview

This work aimed to establish a RapidFire/MS/MS–based bioassay for sirtuin enzymes (SIRT1, SIRT2, SIRT3) that could:

• Measure native peptide substrates and products without fluorescent or radioactive labels
• Differentiate and quantify multiple deacetylation states on a triply acetylated p53 peptide
• Determine kinetic parameters and inhibition profiles with high throughput (≈7 s per sample)

Methodology and Instrumentation

Reactions were performed using recombinant SIRT isoforms and a synthetic p53 peptide spanning amino acids 372–389 with three acetylated lysine residues. Following enzymatic incubation, samples were processed by the Agilent RapidFire high-throughput desalting system coupled to tandem mass spectrometry. Direct MS/MS transitions tracked all possible acetylation states (3ac, 2ac, 1ac, 0ac) in a sustained workflow. Key instrumentation included:

• Agilent RapidFire high-throughput sample handling platform
• Triple quadrupole mass spectrometer for targeted MS/MS detection
• Online solid-phase extraction cartridges for rapid desalting

Key Results and Discussion

The assay achieved a sample-to-sample cycle time of approximately seven seconds, enabling rapid measurement of sequential deacetylation events on the p53 substrate. Time-course experiments revealed distinct kinetic profiles for each SIRT isoform. Inhibition studies with nicotinamide produced IC₅₀ values in agreement with published data, confirming assay accuracy. Label-free, direct detection eliminated artifacts associated with surrogate substrates or coupled reactions, yielding reliable kinetic parameters.

Benefits and Practical Applications

• Label-free quantification avoids fluorescent tag interference and radioactive hazards
• Simultaneous monitoring of multiple product species enhances data richness
• High throughput supports large compound libraries and kinetic titrations
• Direct measurement of native peptides enables precise determination of enzyme mechanisms and inhibitor potency

Future Trends and Potential Applications

• Extension to other epigenetic enzymes (histone acetyltransferases, methyltransferases, demethylases)
• Integration with microfluidic and automated workflows for increased throughput
• Coupling with machine learning for data-driven assay optimization and hit triage
• Development of multiplexed panels for simultaneous profiling of multiple PTMs in biological samples
• Application in clinical biomarker discovery and personalized medicine strategies

Conclusion

The RapidFire/MS/MS platform delivers a robust, label-free, and high-throughput solution for profiling sirtuin activity and deacetylation kinetics. By enabling direct measurement of multiple acetylation states with minimal sample handling, this approach accelerates epigenetic target screening and supports accurate assessment of inhibitor potency in drug discovery workflows.

References

1. Yamamoto H, Schoonjans K, Auwerx J. Sirtuin functions in health and disease. Mol Endocrinol. 2007;21(8):1745–55.
2. Rye PT et al. Advances in Label-Free Screening Approaches for Studying Sirtuin-Mediated Deacetylation. J Biomol Screen. 2011 Sep 12. [Epub ahead of print].
3. Rye PT et al. Advances in Label-Free Screening Approaches for Studying Histone Acetyltransferases. J Biomol Screen. 2011 Sep 9. [Epub ahead of print].
4. Prives C, Manley JL. Why is p53 acetylated? Cell. 2001;107(7):815–8.
5. Porcu M, Chiarugi A. The emerging therapeutic potential of sirtuin-interacting drugs: from cell death to lifespan extension. Trends Pharmacol Sci. 2005;26(2):94–103.
6. Marcotte PA et al. Fluorescence assay of SIRT protein deacetylases using an acetylated peptide substrate and a secondary trypsin reaction. Anal Biochem. 2004;332(1):90–9.